147 related articles for article (PubMed ID: 949520)
21. [Tumors of the upper urinary tract: results of conservative surgery].
Djokic M; Hadzi-Djokic J; Nikolic J; Dragicevic D; Durutovic O; Radivojevic D
Prog Urol; 2001 Dec; 11(6):1231-8. PubMed ID: 11859657
[TBL] [Abstract][Full Text] [Related]
22. Recurrent phyllodes tumours of the breast: pathological features and clinical implications.
Tan EY; Tan PH; Yong WS; Wong HB; Ho GH; Yeo AW; Wong CY
ANZ J Surg; 2006 Jun; 76(6):476-80. PubMed ID: 16768772
[TBL] [Abstract][Full Text] [Related]
23. Urinary hypoxanthine and pseudouridine as indicators of tumor development in mesothelioma-transplanted nude mice.
Buhl L; Dragsholt C; Svendsen P; Hage E; Buhl MR
Cancer Res; 1985 Mar; 45(3):1159-62. PubMed ID: 3838262
[TBL] [Abstract][Full Text] [Related]
24. Vesical vs. extra-vesical patterns of recurrence after the treatment of urothelial upper tract tumors.
Shikanov S; Shapiro A; Baer L; Landau EH; Katz R; Gofrit ON
Urol Oncol; 2008; 26(3):266-70. PubMed ID: 18452817
[TBL] [Abstract][Full Text] [Related]
25. Cytokeratin expression patterns in low-grade papillary urothelial neoplasms of the urinary bladder.
Ramos D; Navarro S; Villamón R; Gil-Salom M; Llombart-Bosch A
Cancer; 2003 Apr; 97(8):1876-83. PubMed ID: 12673713
[TBL] [Abstract][Full Text] [Related]
26. Microsatellite analysis of voided-urine samples for surveillance of low-grade non-muscle-invasive urothelial carcinoma: feasibility and clinical utility in a prospective multicenter study (Cost-Effectiveness of Follow-Up of Urinary Bladder Cancer trial [CEFUB]).
van der Aa MN; Zwarthoff EC; Steyerberg EW; Boogaard MW; Nijsen Y; van der Keur KA; van Exsel AJ; Kirkels WJ; Bangma C; van der Kwast TH
Eur Urol; 2009 Mar; 55(3):659-67. PubMed ID: 18501499
[TBL] [Abstract][Full Text] [Related]
27. Primary urothelial carcinoma of the upper tract: important clinicopathological factors predicting bladder recurrence after surgical resection.
Huang WW; Huang HY; Liao AC; Shiue YL; Tai HL; Lin CM; Wang YH; Lin CN; Shen KH; Li CF
Pathol Int; 2009 Sep; 59(9):642-9. PubMed ID: 19712132
[TBL] [Abstract][Full Text] [Related]
28. Revision surgery in dermatofibrosarcoma protuberans of the trunk and extremities.
Lindner NJ; Scarborough MT; Powell GJ; Spanier S; Enneking WF
Eur J Surg Oncol; 1999 Aug; 25(4):392-7. PubMed ID: 10419710
[TBL] [Abstract][Full Text] [Related]
29. Correlations of pseudouridine in 8-hour and 24-hour urinary samples determined by high-performance liquid chromatography.
Sjølin KE
Urol Res; 1982; 10(5):245-8. PubMed ID: 7164220
[TBL] [Abstract][Full Text] [Related]
30. Factors leading to local recurrence or death after surgical resection of phyllodes tumours of the breast.
de Roos WK; Kaye P; Dent DM
Br J Surg; 1999 Mar; 86(3):396-9. PubMed ID: 10201787
[TBL] [Abstract][Full Text] [Related]
31. Increased urinary excretion of beta-aminoisobutyric acid in a Danish family.
Sjølin KE
Dan Med Bull; 1988 Aug; 35(4):397-9. PubMed ID: 3168560
[TBL] [Abstract][Full Text] [Related]
32. Age dependence of human urinary pseudouridine excretion.
Tritsch GL; Luch JM; Evans JT; Mittelman A
Biochem Med; 1979 Dec; 22(3):387-90. PubMed ID: 533544
[No Abstract] [Full Text] [Related]
33. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.
Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB
Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341
[TBL] [Abstract][Full Text] [Related]
34. Factors influencing tumour relapse after total laryngectomy.
Nikolaou A; Markou K; Petridis D; Vlachtsis K; Nalbantian M; Daniilidis L
B-ENT; 2005; 1(1):1-10. PubMed ID: 15999669
[TBL] [Abstract][Full Text] [Related]
35. Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology.
Raman JD; Ng CK; Boorjian SA; Vaughan ED; Sosa RE; Scherr DS
BJU Int; 2005 Nov; 96(7):1031-5. PubMed ID: 16225523
[TBL] [Abstract][Full Text] [Related]
36. Determination of degradation rates of transfer and ribosomal ribonucleic acids in cultured rat hepatocytes by measuring N6-threoninocarbonyladenosine, dihydrouridine, and pseudouridine in medium using high-performance liquid chromatography.
Topp H; Dörrenhaus A; Bolt H; Schöch G; Föllmann W
Anal Biochem; 1997 Dec; 254(2):200-7. PubMed ID: 9417777
[TBL] [Abstract][Full Text] [Related]
37. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
38. Routine follow-up cystoscopy in detection of recurrence in patients being monitored for bladder cancer.
Raitanen MP; Leppilahti M; Tuhkanen K; Forssel T; Nylund P; Tammela T;
Ann Chir Gynaecol; 2001; 90(4):261-5. PubMed ID: 11820414
[TBL] [Abstract][Full Text] [Related]
39. A less invasive surgical concept for the resection of spinal meningiomas.
Boström A; Bürgel U; Reinacher P; Krings T; Rohde V; Gilsbach JM; Hans FJ
Acta Neurochir (Wien); 2008 Jun; 150(6):551-6; discussion 556. PubMed ID: 18421413
[TBL] [Abstract][Full Text] [Related]
40. Effect of tryptophan and nicotinamide loads on urinary excretion of RNA metabolites by bladder cancer patients.
Nielsen HR; Wolf H; Brown RR
J Natl Cancer Inst; 1977 Sep; 59(3):855-8. PubMed ID: 142844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
